Respiratory physician Lutz Beckert considers chronic obstructive pulmonary disease management, including the prevention of COPD, the importance of smoking cessation and pulmonary rehabilitation, and the lifesaving potential of addressing treatable traits. He also discusses the logic of inhaler therapy, moving from single therapy to dual and triple therapy when indicated, as well as other aspects of management
GPs expecting specialist rights for ‘2 per cent-plus' cannabis products
+News
In print
Summer Hiatus
GPs expecting specialist rights for ‘2 per cent-plus' cannabis products
Monday 6 January 2020, 09:00 AM

We are on our summer break and the editorial office is closed until 13 January. We hope you enjoy this article which is part of Summer Hiatus, an eclectic mix from our news and clinical archives throughout the year, The Conversation and other publications we share content with. Please note the comment function has been turned off while we are away. Happy reading
Kiwi medicinal cannabis companies got fired up this year, and GPs will soon find it easy to prescribe the products. Simon Maude reports on the emergin, Graham Gulbransen 2017, Auckland GP Graham Gulbransen, who specialises in addiction, says he is comfortable with changes to medicinal cannabis regulations
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.